You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 5, May 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Investigation of Mechanisms in Toxic Epidermal Necrolysis Induced by Carbamazepine

Peter S. Friedmann, MD; Ian Strickland; Munir Pirmohamed, PhD; B. Kevin Park, PhD

Arch Dermatol. 1994;130(5):598-604.


Abstract

Background
Erythema multiforme and toxic epidermal necrolysis can occur as serious and even life-threatening adverse drug reactions. The underlying mechanisms are unknown, but evidence suggests that affected individuals may have impaired capacity to detoxify reactive intermediate drug metabolites. Such intermediates may be directly toxic or may react with host tissues to form antigens, evoking an immune response. We describe our investigation of a patient with carbamazepine-induced erythema multiforme and toxic epidermal necrolysis. The inflammatory infiltrate was examined immunocytochemically in lesional skin specimens from the patient, in the patient's patch test response to carbamazepine, and in lesional skin specimens from five other patients with drug-induced erythema multiforme. The patient's lymphocytes were examined both for susceptibility to cytotoxic damage by liver microsome—induced carbamazepine metabolites and for proliferative responses to native carbamazepine, which might indicate cell-mediated immune sensitization.

Observations
Lesions of toxic epidermal necrolysis were more florid, but findings were essentially similar in all the skin samples examined. In the dermis there were CD14+ macrophages, CD1a+ Langerhans cells, and CD3+, CD45RO+ T cells. The CD4-CD8 T-cell ratio was 2:1, and 10% of the T cells were CD25+, suggesting activation by recent encounter with antigen. The epidermis contained CD14+ macrophages and T cells, but the CD8+ cells out-numbered the CD4+ cells. Up to 25% of the T cells were CD25+. Lymphocyte proliferation was not induced by native carbamazepine, but the patient's lymphocytes were significantly more susceptible to cytotoxic killing by liver microsome—induced carbamazepine intermediates.

Conclusions
The inflammatory reaction in skin affected by erythema multiforme and toxic epidermal necrolysis was rich in CD8+ T cells, suggesting an immune cytotoxic reaction. The patient appeared to have a reduced capacity to detoxify reactive intermediates. This, together with the lack of lymphocyte response to native drug but a positive patch test response, suggests that the immune response may be directed at drug-modified epidermal cells.

(Arch Dermatol. 1994;130:598-604)



Author Affiliations

From the Departments of Dermatology (Dr Friedmann and Mr Strickland) and Pharmacology and Therapeutics (Drs Pirmohamed and Park), Liverpool (England) University.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Management of toxic epidermal necrolysis and related syndromes
Mukasa and Craven
Postgrad. Med. J. 2008;84:60-65.
ABSTRACT | FULL TEXT  

Phenytoin and carbamazepine cross reactivity: report of a case and review of literature
Misra et al.
Postgrad. Med. J. 2003;79:703-704.
ABSTRACT | FULL TEXT  

Hypersensitivity Reactions to Carbamazepine: Characterization of the Specificity, Phenotype, and Cytokine Profile of Drug-Specific T Cell Clones
Naisbitt et al.
Mol. Pharmacol. 2003;63:732-741.
ABSTRACT | FULL TEXT  

Cutaneous Drug Reactions
Svensson et al.
Pharmacol. Rev. 2001;53:357-379.
ABSTRACT | FULL TEXT  

TNF{{alpha}} promoter region gene polymorphisms in carbamazepine-hypersensitive patients
Pirmohamed et al.
Neurology 2001;56:890-896.
ABSTRACT | FULL TEXT  

Classification, Clinical Manifestations, and Immunopathological Mechanisms of the Epithelial Variant of Paraneoplastic Autoimmune Multiorgan Syndrome: A Reappraisal of Paraneoplastic Pemphigus
Nguyen et al.
Arch Dermatol 2001;137:193-206.
ABSTRACT | FULL TEXT  

Fortnightly review: Adverse drug reactions
Pirmohamed et al.
BMJ 1998;316:1295-1298.
FULL TEXT  

Role of Delayed Cellular Hypersensitivity and Adhesion Molecules in Amoxicillin-Induced Morbilliform Rashes
Barbaud et al.
Arch Dermatol 1997;133:481-486.
ABSTRACT  

Erythema Multiforme: Should Anyone Care About the Standards of Care?
Rasmussen
Arch Dermatol 1995;131:726-729.
ABSTRACT  

Immune Mechanisms of TEN
Journal Watch Dermatology 1994;1994:10-10.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.